In 2016, the global cytokine market was valued at USD XX million. Considering the historical trend and possible future developments, the market is projected to reach USD XX million by 2022, registering a CAGR of XX%, during 2017-2022 (the forecast period).
Cytokines are a group of immune-mediators, which comprises of TNF-superfamily members, such as, interferons, interleukins, and chemokines. Several cytokines and their receptors have been used to treat various diseases that include rheumatoid arthritis (RA), type I diabetes, multiple sclerosis (MS).
Request sample copy of the report at: http://www.orbisresearch.biz/contacts/request-sample/465099
The cytokine market is a flourishing market. The multi-faceted applications of cytokines in various domains, like prophylactic, diagnostic, and therapeutic use, to cure various diseases, has widened the horizons of the cytokine market, globally. Recent studies have shown promising contribution of cytokines in stem cell therapy, which has been a stimulating factor for investors to invest.
Browse Complete Report Details at: http://www.orbisresearch.biz/reports/index/global-cytokine-market-growth-trends-and-forecasts-2017-2022
Inflammatory cytokines are a potential biomarker for neonatal sepsis, which is a growing cause of neonatal morbidity and mortality, worldwide. Moreover, it is a significant and viable option for cancer therapy with minimal side effects, when compared to chemotherapy and radiation.
Though cytokines are extremely potent, they are designed to work, locally, and, thus, have short half-lives, something that necessitates prolonged administration. This factor condemns cytokine therapies among patients and doctors. In addition, an efficient way to maintain proper cytokine dose over a prolonged time period has not been worked out yet. This problem gets worse when cytokine doses are not given systemically.
Binding to surface receptors on cells, cytokines trigger a variety of biochemical cascades, which ultimately alter gene expression within those cells. In the interim, cancer immunotherapy has improved in areas like specificity, where cytokine therapy is not as effective and is perhaps it’s biggest drawback.
Apart from the drawbacks of cytokine therapy, the diagnostic equipment, like PCR, require skilled labor, extensive laboratory infrastructure, and expensive reagents. These requirements fuel the need for heavy investment, thus, restraining the market.
The global cytokine market has been segmented on the basis of cytokine type (Tumour Necrosis Factor (TNF), Interleukins (IL), Interferon (IFN), Epidermal Growth Factor (EGF), therapeutic application (Cancer & Malignancies, Asthma/Airway Inflammation, Arthritis, and ‘Others’), and region (North America, Europe, Asia-Pacific, the Middle East & Africa, and South America).
The report provides a detailed overview of the use of each cytokine type and their respective devices, along with in-depth analysis and company profiles of the major players and a clear picture of the competitive landscape that currently exists in the market.
The Key Players in the Global Cytokine Market Include:
AbbVie Biotechne Biocon
Johnson & Johnson Novartis
Roche Pfizer Sanofi
Bayer Healthcare Pharmaceuticals Thermo Fisher Scientific
- Market analysis, with region specific assessments and competition analysis
- Market definition along with the identification of key drivers, restraints, opportunities, and challenges
- Identification of factors instrumental in the changing the market scenario, rising prospective opportunities, and identification of key companies that influence the market on the global and regional scale
- Identification and analysis of the macro and micro factors that affect the market
- Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped
Related Topics: Asia-Pacific Cancer Therapy Market – Growth, Trends, and Forecasts (2016- 2021)
Buy this Report Now at: http://www.orbisresearch.biz/contact/purchase/465099